MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GTBP — GT Biopharma Inc. Common Stock
NasdaqGT Biopharma Inc. Common Stock
$6.10
-0.10(-1.61%)
- O
- 6.36
- H
- 6.51
- L
- 6.00
- V
- 62.1K
⏱️ End-of-day dataAs of Oct 2, 2026
GTBP — Latest News & Headlines
6 StoriesWith $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale. - Stock Titan
With $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale. Stock Titan
GT Biopharma regains Nasdaq $1.00 minimum bid compliance after 10-day stretch - TradingView
GT Biopharma regains Nasdaq $1.00 minimum bid compliance after 10-day stretch TradingView
GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock - AD HOC NEWS
GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock AD HOC NEWS
GT Biopharma regains Nasdaq compliance: what it means for GT Biopharma stock - AD HOC NEWS
GT Biopharma regains Nasdaq compliance: what it means for GT Biopharma stock AD HOC NEWS
GT Biopharma stock reports USD 7.75 million financing update - AD HOC NEWS
GT Biopharma stock reports USD 7.75 million financing update AD HOC NEWS
GT Biopharma Expands Series M Preferred Financing Agreement - TipRanks
GT Biopharma Expands Series M Preferred Financing Agreement TipRanks